TMEM35 Inhibitors

TMEM35 inhibitors are compounds that can interfere with the function of the TMEM35 protein, a molecular chaperone essential for the proper folding, assembly, and functional expression of nicotinic acetylcholine receptors (nAChRs) in the brain. These inhibitors range from compounds that directly impact the protein-protein interactions facilitated by TMEM35 to those that indirectly influence its function by targeting related pathways such as protein glycosylation, protein synthesis, and ion channel activity. By inhibiting TMEM35, these compounds can disrupt the stability and function of various nAChR subtypes, leading to a reduction in nAChR-mediated neurotransmission. Some of these inhibitors interact with chaperone proteins or components of the oligosaccharyl transferase (OST) complex, which TMEM35 associates with. These interactions can affect the ability of TMEM35 to stably associate with its partners, thereby influencing its role in nAChR assembly and function.

Given the multifaceted roles of TMEM35 in the folding and assembly of multiple nAChR subtypes, its interaction with ribophorin-1 and ribophorin-2 as part of the OST complex, and its association with calnexin, inhibitors targeting this protein must be versatile in their mechanisms of action. They can operate by affecting the protein's interaction with nAChRs, by disrupting its association with components of the OST complex or other chaperone proteins, or by inhibiting processes like protein synthesis and glycosylation that are crucial for TMEM35 function. Such a broad scope of inhibitory mechanisms reflects the protein's complex involvement in cellular processes and makes it a challenging but intriguing target for further study.